News Articles Tagged: Antiviral Advancements

The Evolving Landscape of Hepatitis C Treatment: Focus on NS5A Inhibitors

An overview of the evolution in Hepatitis C treatment, highlighting the efficacy and development of NS5A inhibitors like BMS-790052.

The Evolution of Tenofovir: Comparing TAF vs. TDF for Antiviral Therapy

NINGBO INNO PHARMCHEM compares Tenofovir Alafenamide (TAF) and Tenofovir Disoproxil Fumarate (TDF), detailing the advantages of TAF in efficacy and safety for HIV and Hepatitis B.

The Future of Influenza Treatment: Advancements with Baloxavir Marboxil

Discussing the advancements Baloxavir Marboxil brings to influenza treatment and prevention, and its potential impact on future antiviral strategies.

The Legacy of Telaprevir in Advancing Hepatitis C Research

Examining the lasting impact of Telaprevir on Hepatitis C research, its role as a benchmark for protease inhibitors, and its contribution to future antiviral strategies.